Skip to the page

Data / Form D filings / Violet Therapeutics, Inc.

Violet Therapeutics, Inc.: Form D filing

Violet Therapeutics, Inc., a company in Cambridge, MA, filed a Form D with the SEC in 2023. The latest, on May 5, 2023, reports $7.4 million sold of a $11.5 million offering to 4 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
ONE MAIN STREET, SUITE 510, Cambridge, MA, 02142
Phone
(508) 344-2319
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2021
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1974912

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 5, 2023New notice$11,486,624$7,449,960$4,036,6644Apr 20, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
William E YelleExecutive Officer, Director
Atsushi UsamiDirector
Meredith FisherExecutive Officer, Director
Jonathan BehrDirector

Other companies in Massachusetts that filed recently

Every Form D from the week of May 1, 2023 · All recent filings in Massachusetts · All recent Other filings

Read from SEC EDGAR. Amount sold is what Violet Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.